Shares of Glenmark Prescribed drugs Ltd had been buying and selling within the inexperienced and a couple of% larger on 21 January after the corporate’s subsidiary, Glenmark Prescribed drugs Inc., USA, introduced the launching of Phytonadione Injectable Emulsion USP, 10 mg/mL single-dose ampules.
The Phytonadione Injectable Emulsion USP, 10 mg/mL, are used to deal with bleeding or blood clotting points which are brought on by vitamin Ok deficiency, circumstances like obstructive jaundice and ulcerative colitis, or sure medicines equivalent to warfarin.
Marc Kikuchi, president and enterprise head, North America of Glenmark Prescribed drugs, stated, “We’re excited to announce the launch of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules, rising our portfolio of merchandise throughout the institutional channel, whereas additionally strengthening our dedication to carry to market high quality and inexpensive alternate options for sufferers.”
Glenmark’s Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules, is each bioequivalent and therapeutically equal to the reference drug, Vitamin K1 Injectable Emulsion USP, 10 mg/mL, produced by Hospira, Inc.
Based on IQVIA gross sales information for the 12-month interval ending November 2024, the marketplace for Vitamin K1 Injectable Emulsion USP, 10 mg/mL, recorded annual gross sales of roughly $19.7 million.
Glenmark Prescribed drugs is a globally targeted, research-driven pharmaceutical firm with experience in Branded, generic, and OTC product segments. The corporate specialises in important therapeutic areas, together with respiratory, dermatology, and oncology.
Glenmark’s US portfolio consists of 201 authorised merchandise and 51 Abbreviated New Drug Purposes (ANDAs) presently pending FDA approval. Along with its in-house improvement, Glenmark actively collaborates with exterior companions to reinforce its pipeline and portfolio.
The corporate operates 11 superior manufacturing amenities throughout 4 continents and has a presence in additional than 80 international locations worldwide.
At 11:42 am, the shares of Glenmark Pharma had been buying and selling 0.21% larger at Rs 1,506.75 on NSE.
The way forward for investing is right here!
Unicorn Alerts leverages superior AI know-how to give you highly effective market predictions and actionable inventory scans. Obtain the app as we speakand 10x your buying and selling & investing journey!
